Clinical Trial Update: Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

View source ↗

Summary

Observational study of Vectibix with chemotherapy for metastatic colorectal cancer has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Wild-type RAS Metastatic Colorectal Cancer | Status: COMPLETED | Results posted: 2018-08-20